Humanized anti-C5a antibodies and uses thereof
Inhibition of complement signaling using a humanized anti-C5a antibody is provided. Methods of treating a complement-mediated disease or a complement-mediated condition in an individual by contacting the individual with a humanized anti-C5a antibody are provided. 提供了使用人源化抗C5a抗体对补体信号传导的抑制。提供了通过使个体与人源...
Gespeichert in:
| Hauptverfasser: | , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | chi ; eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | QI SHIGANG GULLIPALLI, DAMODARA RAO CUI PING ZHU XIHUA SONG WENCHAO MIWA TAKASHI ZHANG JIANJUN SATO SAYAKA |
| description | Inhibition of complement signaling using a humanized anti-C5a antibody is provided. Methods of treating a complement-mediated disease or a complement-mediated condition in an individual by contacting the individual with a humanized anti-C5a antibody are provided.
提供了使用人源化抗C5a抗体对补体信号传导的抑制。提供了通过使个体与人源化抗C5a抗体接触来治疗个体中补体介导的疾病或补体介导的病症的方法。 |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CN117999288A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CN117999288A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CN117999288A3</originalsourceid><addsrcrecordid>eNrjZNDzKM1NzMusSk1RSMwrydR1Nk0EM5LyUzJTi4HMFIXSYiCjJCO1KDU_jYeBNS0xpziVF0pzMyi6uYY4e-imFuTHpxYXJCan5qWWxDv7GRqaW1paGllYOBoTowYAxggqOg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Humanized anti-C5a antibodies and uses thereof</title><source>esp@cenet</source><creator>QI SHIGANG ; GULLIPALLI, DAMODARA RAO ; CUI PING ; ZHU XIHUA ; SONG WENCHAO ; MIWA TAKASHI ; ZHANG JIANJUN ; SATO SAYAKA</creator><creatorcontrib>QI SHIGANG ; GULLIPALLI, DAMODARA RAO ; CUI PING ; ZHU XIHUA ; SONG WENCHAO ; MIWA TAKASHI ; ZHANG JIANJUN ; SATO SAYAKA</creatorcontrib><description>Inhibition of complement signaling using a humanized anti-C5a antibody is provided. Methods of treating a complement-mediated disease or a complement-mediated condition in an individual by contacting the individual with a humanized anti-C5a antibody are provided.
提供了使用人源化抗C5a抗体对补体信号传导的抑制。提供了通过使个体与人源化抗C5a抗体接触来治疗个体中补体介导的疾病或补体介导的病症的方法。</description><language>chi ; eng</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS THEREOF ; CULTURE MEDIA ; ENZYMOLOGY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; MICROBIOLOGY ; MICROORGANISMS OR ENZYMES ; MUTATION OR GENETIC ENGINEERING ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ; SPIRITS ; VINEGAR ; WINE</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240507&DB=EPODOC&CC=CN&NR=117999288A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240507&DB=EPODOC&CC=CN&NR=117999288A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>QI SHIGANG</creatorcontrib><creatorcontrib>GULLIPALLI, DAMODARA RAO</creatorcontrib><creatorcontrib>CUI PING</creatorcontrib><creatorcontrib>ZHU XIHUA</creatorcontrib><creatorcontrib>SONG WENCHAO</creatorcontrib><creatorcontrib>MIWA TAKASHI</creatorcontrib><creatorcontrib>ZHANG JIANJUN</creatorcontrib><creatorcontrib>SATO SAYAKA</creatorcontrib><title>Humanized anti-C5a antibodies and uses thereof</title><description>Inhibition of complement signaling using a humanized anti-C5a antibody is provided. Methods of treating a complement-mediated disease or a complement-mediated condition in an individual by contacting the individual with a humanized anti-C5a antibody are provided.
提供了使用人源化抗C5a抗体对补体信号传导的抑制。提供了通过使个体与人源化抗C5a抗体接触来治疗个体中补体介导的疾病或补体介导的病症的方法。</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS THEREOF</subject><subject>CULTURE MEDIA</subject><subject>ENZYMOLOGY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MICROORGANISMS OR ENZYMES</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><subject>SPIRITS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNDzKM1NzMusSk1RSMwrydR1Nk0EM5LyUzJTi4HMFIXSYiCjJCO1KDU_jYeBNS0xpziVF0pzMyi6uYY4e-imFuTHpxYXJCan5qWWxDv7GRqaW1paGllYOBoTowYAxggqOg</recordid><startdate>20240507</startdate><enddate>20240507</enddate><creator>QI SHIGANG</creator><creator>GULLIPALLI, DAMODARA RAO</creator><creator>CUI PING</creator><creator>ZHU XIHUA</creator><creator>SONG WENCHAO</creator><creator>MIWA TAKASHI</creator><creator>ZHANG JIANJUN</creator><creator>SATO SAYAKA</creator><scope>EVB</scope></search><sort><creationdate>20240507</creationdate><title>Humanized anti-C5a antibodies and uses thereof</title><author>QI SHIGANG ; GULLIPALLI, DAMODARA RAO ; CUI PING ; ZHU XIHUA ; SONG WENCHAO ; MIWA TAKASHI ; ZHANG JIANJUN ; SATO SAYAKA</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CN117999288A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng</language><creationdate>2024</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS THEREOF</topic><topic>CULTURE MEDIA</topic><topic>ENZYMOLOGY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MICROORGANISMS OR ENZYMES</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><topic>SPIRITS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>QI SHIGANG</creatorcontrib><creatorcontrib>GULLIPALLI, DAMODARA RAO</creatorcontrib><creatorcontrib>CUI PING</creatorcontrib><creatorcontrib>ZHU XIHUA</creatorcontrib><creatorcontrib>SONG WENCHAO</creatorcontrib><creatorcontrib>MIWA TAKASHI</creatorcontrib><creatorcontrib>ZHANG JIANJUN</creatorcontrib><creatorcontrib>SATO SAYAKA</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>QI SHIGANG</au><au>GULLIPALLI, DAMODARA RAO</au><au>CUI PING</au><au>ZHU XIHUA</au><au>SONG WENCHAO</au><au>MIWA TAKASHI</au><au>ZHANG JIANJUN</au><au>SATO SAYAKA</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Humanized anti-C5a antibodies and uses thereof</title><date>2024-05-07</date><risdate>2024</risdate><abstract>Inhibition of complement signaling using a humanized anti-C5a antibody is provided. Methods of treating a complement-mediated disease or a complement-mediated condition in an individual by contacting the individual with a humanized anti-C5a antibody are provided.
提供了使用人源化抗C5a抗体对补体信号传导的抑制。提供了通过使个体与人源化抗C5a抗体接触来治疗个体中补体介导的疾病或补体介导的病症的方法。</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | chi ; eng |
| recordid | cdi_epo_espacenet_CN117999288A |
| source | esp@cenet |
| subjects | BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS VINEGAR WINE |
| title | Humanized anti-C5a antibodies and uses thereof |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T11%3A34%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=QI%20SHIGANG&rft.date=2024-05-07&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECN117999288A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |